Dantrolene Sodium Capsule
FDA Label NDC 0904-7211

27 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Dantrolene Sodium (NDC 0904-7211). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, clinical pharmacology, in chronic spasticity, in malignant hyperthermia, contraindications, warnings, carcinogenesis, mutagenesis, impairment of fertility, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-7211-04

Unit Dose

DANTROLENE SODIUM

CAPSULES, USP

25 mg

PERIPHERAL SKELETAL

MUSCLE RELAXANT

Rx only

30 CAPSULES

25mg Carton Label (C254d463 2f1c 4c34 9db0 917a7bac870f 00)

25mg Carton Label (C254d463 2f1c 4c34 9db0 917a7bac870f 00)

* Please review the disclaimer below.